F Stenbäck|A Kauppila - JoVE Visualize

Showing results (1-10 of 341) with videos related to

Pageof 35

Sort By:

Gynecologic and Obstetric Investigation|January 1, 1981

Endometrioid ovarian tumors: morphology and relation to other endometrial conditionsF Stenbäck, A Kauppila

Gynecologic and Obstetric Investigation|January 1, 1981

Development and classification of parovarian cysts. An ultrastructural studyF Stenbäck, A Kauppila

European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1980

Surface ultrastructure of human endometrium. Effect of hormonal status and neoplastic progressionF Stenbäck, R Väänänen, A Kauppila

Archives of Gynecology|January 1, 1982

Screening of asymptomatic postmenopausal women for gynecological malignancies, with special reference to endometrial sampling methodsS Vuopala, A Kauppila, M Mikkonen, et al.

Gynecologic and Obstetric Investigation|January 1, 1988

Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapyA Kauppila, S Kivinen, F Stenbäck, et al.

Gynecologic Oncology|January 15, 1999

Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovaryM Santala, H Burger, A Ruokonen, et al.

Obstetrics and Gynecology|March 1, 1983

Clinical significance of estrogen and progestin receptors in ovarian cancerA Kauppila, P Vierikko, S Kivinen, et al.

International Journal of Cancer|February 15, 1985

Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinomaA Kauppila, H Isotalo, S Kivinen, et al.

Cancer|September 1, 1993

Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical studyG G Zhu, F Stenbäck, L Risteli, et al.

The American Journal of Pathology|February 1, 1996

Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomasS Kauppila, J Saarela, F Stenbäck, et al.

Pageof 35

Showing results (1-10 of 341) with videos related to

Sort By:

Pageof 35

Gynecologic and Obstetric Investigation|January 1, 1981

Endometrioid ovarian tumors: morphology and relation to other endometrial conditionsF Stenbäck, A Kauppila

Gynecologic and Obstetric Investigation|January 1, 1981

Development and classification of parovarian cysts. An ultrastructural studyF Stenbäck, A Kauppila

European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 1, 1980

Surface ultrastructure of human endometrium. Effect of hormonal status and neoplastic progressionF Stenbäck, R Väänänen, A Kauppila

Archives of Gynecology|January 1, 1982

Screening of asymptomatic postmenopausal women for gynecological malignancies, with special reference to endometrial sampling methodsS Vuopala, A Kauppila, M Mikkonen, et al.

Gynecologic and Obstetric Investigation|January 1, 1988

Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapyA Kauppila, S Kivinen, F Stenbäck, et al.

Gynecologic Oncology|January 15, 1999

Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovaryM Santala, H Burger, A Ruokonen, et al.

Obstetrics and Gynecology|March 1, 1983

Clinical significance of estrogen and progestin receptors in ovarian cancerA Kauppila, P Vierikko, S Kivinen, et al.

International Journal of Cancer|February 15, 1985

Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinomaA Kauppila, H Isotalo, S Kivinen, et al.

Cancer|September 1, 1993

Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical studyG G Zhu, F Stenbäck, L Risteli, et al.

The American Journal of Pathology|February 1, 1996

Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomasS Kauppila, J Saarela, F Stenbäck, et al.

Pageof 35